All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

All seven independent directors of 23andMe resigned from the board, citing disagreements with CEO Anne Wojcicki regarding the ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Following a monthslong battle over CEO Anne Wojcicki’s plans to take 23andMe ... Its price on IPO day was $10; so far in 2024, it has yet to reach a $1 valuation. Following the resignation ...

Sep 12, 2024, 9:22am EDT Updated: Sep 12, 2024, 9:47am EDT Kimberly White/Getty Images for Breakthrough Prize 23andMe CEO Anne Wojcicki ... like many others in the life sciences research and ...

US stock futures tick higher ahead of an all-important Federal Reserve interest rate decision on Wednesday, with debate swirling around whether the central bank will choose to potentially cut ...

Seven independent members of the company’s eight-person board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s ... the proposal the next day, saying it offered ...

Co-Founder and CEO Anne Wojcicki has failed to offer an actionable ... raising nearly $600 million as its stock shot 21% higher on its first day of trading. But consumer demand for its DNA-testing ...

CEO and co-founder Anne Wojcicki ... that because of Wojcicki’s “concentrated voting power,” they’re done, effective immediately. The company’s market cap closed the day at $173 million.